SPS 182.03(1)(j)
(j) Reevaluate maternal and newborn well being within 36 hours of delivery.
SPS 182.03(1)(L)
(L) Ensure that a birth certificate is accurately completed and filed in accordance with state law.
SPS 182.03(1)(m)
(m) Offer to obtain and submit a blood sample in accordance with the recommendations for metabolic screening of the newborn.
SPS 182.03(1)(n)
(n) Offer an injection of vitamin K for the newborn in accordance with the indication, dose and administration route set forth in sub.
(3).
SPS 182.03(1)(o)
(o) Within one week of delivery, offer a newborn hearing screening to every newborn or refer the parents to a facility with a newborn hearing screening program.
SPS 182.03(1)(p)
(p) Within 2 hours of the birth offer the administration of antibiotic ointment into the eyes of the newborn, in accordance with state law on the prevention of infant blindness.
SPS 182.03(1)(q)
(q) Maintain adequate antenatal and perinatal records of each client and provide records to consulting licensed physicians and licensed certified nurse-midwives, in accordance with HIPAA regulations.
SPS 182.03(2)
(2) Prescription drugs, devices and procedures. A licensed midwife may administer the following during the practice of midwifery:
SPS 182.03(2)(b)
(b) Eye prophylactics – 0.5% erythromycin ophthalmic ointment or 1% tetracycline ophthalmic ointment for the prevention of neonatal ophthalmia.
SPS 182.03(2)(c)
(c) Oxytocin, or pitocin, as a postpartum antihemorrhagic agent.
SPS 182.03(2)(d)
(d) Methyl-ergonovine, or methergine, for the treatment of postpartum hemorrhage.
SPS 182.03(2)(e)
(e) Vitamin K for the prophylaxis of hemorrhagic disease of the newborn.
SPS 182.03(2)(f)
(f) RHo (D) immune globulin for the prevention of RHo (D) sensitization in RHo (D) negative women.
SPS 182.03(2)(g)
(g) Intravenous fluids for maternal stabilization – 5% dextrose in lactated Ringer's solution (D5LR), unless unavailable or impractical in which case 0.9% sodium chloride may be administered.
SPS 182.03(2)(h)
(h) In addition to the drugs, devices and procedures that are identified in pars.
(a) to
(g), a licensed midwife may administer any other prescription drug, use any other device or perform any other procedure as an authorized agent of a licensed practitioner with prescriptive authority.
SPS 182.03 Note
Note: Licensed midwives do not possess prescriptive authority. A licensed midwife may legally administer prescription drugs or devices only as an authorized agent of a practitioner with prescriptive authority. For physicians and advanced practice nurses, an agent may administer prescription drugs or devices pursuant to written standing orders and protocols.
SPS 182.03 Note
Note: Medical oxygen, 0.5% erythromycin ophthalmic ointment, tetracycline ophthalmic ointment, oxytocin (pitocin), methyl-ergonovine (methergine), injectable vitamin K and RHo (D) immune globulin are prescription drugs. See s.
SPS 180.02 (1).
SPS 182.03(3)
(3) Indications, dose, administration and duration of treatment. The indications, dose, route of administration and duration of treatment relating to the administration of drugs and procedures identified under sub.
(2) are as follows: -
See PDF for table 
SPS 182.03(4)(a)
(a) A licensed midwife shall consult with a licensed physician or a licensed certified nurse-midwife providing obstetrical care, whenever there are significant deviations, including abnormal laboratory results, relative to a client's pregnancy or to a neonate. If a referral to a physician is needed, the licensed midwife shall refer the client to a physician and, if possible, remain in consultation with the physician until resolution of the concern.
SPS 182.03 Note
Note: Consultation does not preclude the possibility of an out-of-hospital birth. It is appropriate for the licensed midwife to maintain care of the client to the greatest degree possible, in accordance with the client's wishes, during the pregnancy and, if possible, during labor, birth and the postpartum period.
SPS 182.03(4)(b)
(b) A licensed midwife shall consult with a licensed physician or certified nurse-midwife with regard to any mother who presents with or develops the following risk factors or presents with or develops other risk factors that in the judgment of the licensed midwife warrant consultation:
SPS 182.03(4)(b)1.a.
a. Pregnancy induced hypertension, as evidenced by a blood pressure of 140/90 on 2 occasions greater than 6 hours apart.
SPS 182.03(4)(b)1.d.
d. Significant vaginal bleeding before the onset of labor not associated with uncomplicated spontaneous abortion.
SPS 182.03(4)(b)1.k.
k. Isoimmunization, Rh-negative sensitized, positive titers, or any other positive antibody titer, which may have a detrimental effect on mother or fetus.
SPS 182.03(4)(b)1.o.
o. Symptoms of malnutrition or anorexia or protracted weight loss or failure to gain weight.
SPS 182.03(4)(b)1.r.
r. Documented low lying placenta in woman with history of previous cesarean delivery.
SPS 182.03(4)(b)2.a.
a. Rise in blood pressure above baseline, more than 30/15 points or greater than 140/90.
SPS 182.03(4)(b)2.f.
f. Significant bleeding prior to delivery or any abnormal bleeding, with or without abdominal pain; or evidence of placental abruption.
SPS 182.03(4)(b)2.h.
h. Failure to progress after 5 hours of active labor or following 2 hours of active second stage labor.
SPS 182.03(4)(c)
(c) A licensed midwife shall consult with a licensed physician or licensed certified nurse-midwife with regard to any neonate who is born with or develops the following risk factors:
SPS 182.03(4)(c)1.
1. Apgar score of 6 or less at 5 minutes without significant improvement by 10 minutes.
